- Home
- AGMH vs CNSP Comparison
AGMH vs CNSP Comparison
Compare AGMH & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGMH
- CNSP
- Stock Information
- Founded
- AGMH 2015
- CNSP 2017
- Country
- AGMH Hong Kong
- CNSP United States
- Employees
- AGMH N/A
- CNSP N/A
- Industry
- AGMH EDP Services
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- AGMH Technology
- CNSP Health Care
- Exchange
- AGMH Nasdaq
- CNSP Nasdaq
- Market Cap
- AGMH 3.9M
- CNSP 4.0M
- IPO Year
- AGMH 2018
- CNSP 2019
- Fundamental
- Price
- AGMH $2.33
- CNSP $7.43
- Analyst Decision
- AGMH
- CNSP Hold
- Analyst Count
- AGMH 0
- CNSP 1
- Target Price
- AGMH N/A
- CNSP N/A
- AVG Volume (30 Days)
- AGMH 734.4K
- CNSP 77.5K
- Earning Date
- AGMH 05-13-2025
- CNSP 08-14-2025
- Dividend Yield
- AGMH N/A
- CNSP N/A
- EPS Growth
- AGMH N/A
- CNSP N/A
- EPS
- AGMH 6.43
- CNSP N/A
- Revenue
- AGMH $32,044,575.00
- CNSP N/A
- Revenue This Year
- AGMH N/A
- CNSP N/A
- Revenue Next Year
- AGMH N/A
- CNSP N/A
- P/E Ratio
- AGMH $0.33
- CNSP N/A
- Revenue Growth
- AGMH N/A
- CNSP N/A
- 52 Week Low
- AGMH $1.09
- CNSP $4.93
- 52 Week High
- AGMH $109.50
- CNSP $221.94
- Technical
- Relative Strength Index (RSI)
- AGMH 55.05
- CNSP 58.83
- Support Level
- AGMH $1.92
- CNSP $5.88
- Resistance Level
- AGMH $4.38
- CNSP $6.37
- Average True Range (ATR)
- AGMH 0.47
- CNSP 0.47
- MACD
- AGMH 0.05
- CNSP 0.28
- Stochastic Oscillator
- AGMH 29.19
- CNSP 81.49
About AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.